Short-course immunosuppression using FK506 for rat tracheal allografts

Journal of Cardiovascular Surgery

Volumn 41, Issue 3, 2000, Pages 487-492

  Hashimoto, M ^a   Nakanishi, R ^a   Muranaka, H ^a   Umesue, M ^a   Eifuku, R ^a   Yasumoto, K ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Immunosuppression; Rats; Trachea transplantation; Transplantation, homologous

Indexed keywords

TACROLIMUS;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; OMENTUM; RAT; TRACHEA GRAFT; TRACHEA SURGERY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAFT REJECTION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; OMENTUM; RANDOM ALLOCATION; RATS; RATS, INBRED BN; RATS, INBRED LEW; TACROLIMUS; TISSUE TRANSPLANTATION; TRACHEA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033938143     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rose KG, Sesterhenn K, Wustrow F. Tracheal allotransplantation in man. Lancet 1979:433.
2. Nakanishi R, Yasumoto K. Minimal dose of cyclosporin A for tracheal allografts. Ann Thorac Surg 1995;60:635-9.
3. Nakanishi R, Yasumoto K, Shirakusa T. Short course immunosuppression after tracheal allotransplantation in dogs. J Thorac Cardiovasc Surg 1995;109:910-7.
4. Shiraga T, Matsuda H, Nagase K. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome p450 3A enzymes in rat, dog and human liver microsomes. Biochem Pharmacol 1994;47: 727-35.
5. Bierer BE. Biology of cyclosporin A and FK506. Prog Clin Biol Res 1994;390:203-23.
6. Ohara K, Billington R, James RW, Dean GA, Nishiyama M, Noguchi H. Toxicologic evaluation of FK506. Transplant Proc 1990;22:83-6.
7. Nakanishi R, Hanagiri T, Shirakusa T. Early histopathologic features of tracheal allotransplant rejection: a study in nonimmunosuppressed dog. Transplant Proc 1994;26:3715-8.
8. Ohtsuka S, Hayashi S, Sato E. The effect of short-term FK506 therapy on pancreas transplantation in rats. Transplant Proc 1991;23: 3217-8.
9. Murase N, Srartzl TE, Tanabe M, Fujisaki S, Miyazawa H, Ye Q et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 1995;60:158-71.
10. Cai X, Hamada J, Rao PN, Flowers J, Venkataramanan R, Warthy V et al. Low-dose of FK506 and associated blood levels in allotransplantation of rat liver, heart, and skin. Transplant Proc 1992;24: 1403-5.
11. Moriyama S, Shimizu N, Teramoto S. Experimental tracheal allotransplantation using omentopexy. Transplant Proc 1989;21:2596-600.
12. Hirai T, Tomas KW, Kleber ND, Christopher GC, Wada H, Hitomi S et al. A short course of FK506 can induce limited donor-specific graft acceptance. Ann Thorac Surg 1994;58:496-501.
13. Murase N, Kim DG, Todo S, Cramer DV, Fung J, Starzl TE. Inducton of liver, heart, and and mulutivisceral graft acceptance with a short course of FK506. Transplant Proc 1990;22:74-5.
14. Nakanishi R, Shirakusa T, Takachi T. Omentopexy for tracheal autografts. Ann Thorac Surg 1994;57:841-5.